Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

Clinical trial NCT06561347 · RECRUITING

Trial details

NCT number: NCT06561347
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Waldenstrom Macroglobulinemia

Start date: 2024-12-20
Primary completion: 2026-12-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.